NAPRT and ovarian carcinoma: The docking results were thoroughly inspected and resulted in a selection of 62 compounds (Table 1 and Table S1 of Supplementary Information) to be tested employing in vitro assays on the ovarian cancer cell line OVCAR-5 that expresses high levels of NAPRT.